2021 Media Kit

JAIDS: Journal of Acquired Immune Deficiency Syndromes

  • 174 Total Subscribers
  • 26,997 Average Monthly Visits



Content Focus

JAIDS: Journal of Acquired Immune Deficiency Syndrome seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide.

JAIDS: Journal of Acquired Immune Deficiency Syndrome is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.

Impact Factor


Impact Factor Ranking

Infectious Diseases 34/93
Immunology 78/158


Paul A. Volberding, MD
William A. Blattner, MD


15 issues per year

Advertising Guidelines

Subject to approval by Editor. New copy must be received by the Publisher two weeks before closing date.